)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
China Resources Boya Bio-pharmaceutical Group (300294) investor relations material
China Resources Boya Bio-pharmaceutical Group Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary28 Oct, 2025
Executive summary
Revenue for Q3 2025 reached ¥466.15 million, up 33.43% year-over-year; YTD revenue was ¥1.47 billion, up 18.38% year-over-year, mainly due to the consolidation of Green Cross.
Net profit attributable to shareholders for Q3 was ¥117.62 million, up 21.59% year-over-year; YTD net profit was ¥342.96 million, down 16.90% year-over-year, impacted by inventory write-downs and asset amortization from the Green Cross acquisition.
Net profit excluding non-recurring items for Q3 was ¥44.35 million, down 42.59% year-over-year; YTD was ¥209.90 million, down 37.55% year-over-year, mainly due to lower net profit and the disposal of Boya Xinhe.
Operating cash flow for Q3 was ¥26.11 million, down 90.05% year-over-year, due to increased consolidation scope and slower cash collection.
Financial highlights
Basic and diluted EPS for Q3 were ¥0.23, up 21.05% year-over-year; YTD EPS was ¥0.68, down 17.07% year-over-year.
Total assets at quarter-end were ¥8.73 billion, up 3.88% from year-end 2024; shareholders' equity was ¥7.67 billion, up 2.45%.
Significant non-recurring gains included government subsidies and financial asset fair value changes totaling ¥133.06 million YTD.
Cash and cash equivalents decreased 41.40% to ¥761.75 million, mainly due to investments in wealth management, project payments, and dividends.
Outlook and guidance
Management expects continued impact from the Green Cross acquisition on profitability due to inventory and asset amortization.
Market and reimbursement environment remains challenging, affecting cash collection and receivables.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next China Resources Boya Bio-pharmaceutical Group earnings date
H2 202518 Mar, 2026
Next China Resources Boya Bio-pharmaceutical Group earnings date
H2 202518 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
China Resources Boya Bio-pharmaceutical Group Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and distribution of plasma-derived biopharmaceutical products. The company's offerings include a range of products for immune system support, blood coagulation, and other therapeutic uses. China Resources Boya operates production facilities and leverages advanced bioprocessing technologies to ensure high standards in the manufacturing and quality control of its products. In addition to its focus on healthcare needs, the company also engages in initiatives aimed at expanding its biopharmaceutical pipeline. China Resources Boya Bio-pharmaceutical Group is headquartered in Chengdu, China, and its shares are listed on the Shenzhen Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage